T1	Disease 306 314	COVID-19
T4	Organism 124 129	human
T5	OrganismPart 130 135	blood
T6	CellType 7292 7317	Highly purified platelets
T2	FragmentationMethod 13487 13525	higher-energy collisional dissociation
T7	AcquisitionMethod 13444 13447	DDA
T8	Instrument 13078 13137	Orbitrap Fusion(TM) Lumos(TM) Tribrid(TM) Mass Spectrometer
T9	NumberOfMissedCleavages 17216 17217	2
T10	Separation 12696 12715	Acclaim PepMap RSLC
T11	PrecursorMassTolerance 17314 17321	4.5 ppm
T12	FragmentMassTolerance 17378 17384	20 ppm
T13	AlkylationReagent 9711 9724	iodoacetamide
T14	ReductionReagent 9611 9625	dithiothreitol
T15	CleavageAgent 10275 10282	trypsin
T16	Modification 17420 17440	Methionine oxidation
A1	Modification T16 variable
T17	Modification 17490 17519	cysteine carbamidomethylation
A2	Modification T17 fixed
T18	NumberOfSamples 20863 20865	19
T19	Sex 21391 21395	male
T20	Label 17978 17988	label-free
T21	IonizationType 13023 13035	electrospray
T22	CollisionEnergy 13549 13580	28% normalized collision energy
T23	MS2MassAnalyzer 13866 13874	orbitrap
T3	FactorValue 731 740	survivors
T24	FactorValue 745 758	non-survivors
